Phibro Animal Health (PAHC) Net Income Growth (1y) (2013 - 2026)
Phibro Animal Health (PAHC) Net Income Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | -304.98% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -5.04% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -105.67% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 7.59% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -2,482.61% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 34.33% |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 390.91% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 125.68 Mn | 15.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.06% |
| Dec 31, 2025 | 762.14% |
| Sep 30, 2025 | 280.32% |
| Jun 30, 2025 | 138.29% |
| Mar 31, 2025 | 148.42% |
| Dec 31, 2024 | 150.00% |
| Sep 30, 2024 | 187.02% |
| Jun 30, 2024 | -491.19% |
| Mar 31, 2024 | -16.30% |
| Dec 31, 2023 | -82.33% |
| Sep 30, 2023 | -307.86% |
| Jun 30, 2023 | 53.57% |
| Mar 31, 2023 | -43.23% |
| Dec 31, 2022 | -58.72% |
| Sep 30, 2022 | -40.99% |
| Jun 30, 2022 | -49.88% |
| Mar 31, 2022 | 45.46% |
| Dec 31, 2021 | 36.43% |
| Sep 30, 2021 | -46.89% |
| Jun 30, 2021 | 133.28% |